Skip to content
Screener

Summit Therapeutics SMMT Q2 2026 earnings

Reported July 23, 2026 · After market close

EPS-$0.28Miss by $0.01
Revenue estimate$114.0K
EPS estimate-$0.27

Next report

Oct 19, 2026 (in 2 months)
Revenue estimate$71.4K
EPS estimate-$0.28

FAQ

When did Summit Therapeutics report Q2 2026 earnings?
Summit Therapeutics (SMMT) reported Q2 2026 earnings on July 23, 2026 after market close.
What were Summit Therapeutics's Q2 2026 revenue and EPS?
Summit Therapeutics reported eps of $-0.28 for Q2 2026.
Did Summit Therapeutics beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.27 by $0.01.
How did Summit Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 63.2% from $-0.76.
Where can I find Summit Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001599298-26-000058) and the 10-Q periodic report (0001599298-26-000068) directly on SEC EDGAR. The filing index links above go to sec.gov.